糖尿病合并慢性肾脏病3b期及以上（估算肾小球滤过率<45 mL/分钟）患者管理的临床实践指南 - Suppr

Suppr

超能文献

Clinical Practice Guideline on management of patients with diabetes and chronic kidney disease stage 3b or higher (eGFR <45 mL/min).

出版信息

Nephrol Dial Transplant. 2015 May;30 Suppl 2:ii1-142. doi: 10.1093/ndt/gfv100.

DOI:10.1093/ndt/gfv100

PMID:25940656

Abstract

摘要

相似文献

Clinical Practice Guideline on management of patients with diabetes and chronic kidney disease stage 3b or higher (eGFR <45 mL/min).糖尿病合并慢性肾脏病3b期及以上（估算肾小球滤过率<45 mL/分钟）患者管理的临床实践指南

Nephrol Dial Transplant. 2015 May;30 Suppl 2:ii1-142. doi: 10.1093/ndt/gfv100.

The UKPDS. A model for gathering the evidence for the management of chronic diseases. UK Prospective Diabetes Study Group.英国前瞻性糖尿病研究（UKPDS）。收集慢性病管理证据的典范。英国前瞻性糖尿病研究小组。

J R Coll Physicians Lond. 1998 Nov-Dec;32(6):510-1.

Clinical inertia-Time to reappraise the terminology?临床惰性——是时候重新评估这个术语了吗？

Prim Care Diabetes. 2017 Apr;11(2):105-106. doi: 10.1016/j.pcd.2017.01.007. Epub 2017 Feb 20.

Putting HAIs, the nephrologist at center stage.

Nephrol News Issues. 2017 Mar;31(3):20-21.

[French translation of the clinical practice guideline on management of patients with diabetes and chronic kidney disease stage 3B or higher (eGFR<45mL/min/1.73 m)].糖尿病合并慢性肾脏病3B期及以上（估算肾小球滤过率<45mL/（min·1.73m²））患者管理临床实践指南的法语译本

Nephrol Ther. 2017 May;13(3):138-145. doi: 10.1016/j.nephro.2016.05.011. Epub 2016 Dec 21.

The impact of clinical practice guidelines should not be overestimated.临床实践指南的影响不应被高估。

J Am Board Fam Pract. 2004 Nov-Dec;17(6):474-5; author reply 475.

Canadian Primary Care Physicians' Attitudes Toward Understanding Clinical Practice Guidelines for Diabetes Screening.加拿大初级保健医生对理解糖尿病筛查临床实践指南的态度。

Can J Diabetes. 2016 Dec;40(6):580-585. doi: 10.1016/j.jcjd.2016.05.018. Epub 2016 Aug 30.

Antihyperglycemic Medication Use Among Medicare Beneficiaries With Heart Failure, Diabetes Mellitus, and Chronic Kidney Disease.患有心力衰竭、糖尿病和慢性肾脏病的医疗保险受益人的降糖药物使用情况

Circ Heart Fail. 2016 Jul;9(7). doi: 10.1161/CIRCHEARTFAILURE.115.002638.

Proposed QOF indicators target diabetes prevention.

BMJ. 2017 Feb 14;356:j829. doi: 10.1136/bmj.j829.

The new BNMS guidelines for measurement of glomerular filtration rate.肾小球滤过率测量的新BNMS指南。

Nucl Med Commun. 2004 Aug;25(8):755-7. doi: 10.1097/01.mnm.0000136714.77658.4a.

引用本文的文献

Can we slow down the decline in renal function?我们能减缓肾功能衰退吗？

Eur Heart J Suppl. 2025 Feb 19;27(Suppl 1):i149-i153. doi: 10.1093/eurheartjsupp/suae123. eCollection 2025 Feb.

Machine learning models predict the progression of long-term renal insufficiency in patients with renal cancer after radical nephrectomy.机器学习模型可预测肾癌患者根治性肾切除术后长期肾功能不全的进展情况。

BMC Nephrol. 2024 Dec 18;25(1):450. doi: 10.1186/s12882-024-03907-1.

Does the Composition of Gut Microbiota Affect Chronic Kidney Disease? Molecular Mechanisms Contributed to Decreasing Glomerular Filtration Rate.肠道微生物组成是否会影响慢性肾脏病？降低肾小球滤过率的分子机制。

Int J Mol Sci. 2024 Sep 27;25(19):10429. doi: 10.3390/ijms251910429.

Association between gut microbiota and diabetic nephropathy: a two-sample Mendelian randomization study.肠道微生物群与糖尿病肾病的关联：一项两样本 Mendelian 随机研究。

Front Endocrinol (Lausanne). 2024 Jul 4;15:1361440. doi: 10.3389/fendo.2024.1361440. eCollection 2024.

De-indexed estimated glomerular filtration rates for the dosing of oral antidiabetic drugs in patients with chronic kidney disease.用于慢性肾脏病患者口服降糖药给药的去指数化估计肾小球滤过率

Front Pharmacol. 2024 Jul 4;15:1375838. doi: 10.3389/fphar.2024.1375838. eCollection 2024.

Effectiveness of DialBetesPlus, a self-management support system for diabetic kidney disease: Randomized controlled trial.糖尿病肾病自我管理支持系统DialBetesPlus的有效性：随机对照试验。

NPJ Digit Med. 2024 Apr 27;7(1):104. doi: 10.1038/s41746-024-01114-8.

Metformin-Associated Lactic Acidosis in Individuals Without Chronic Kidney Disease on Therapeutic Dose: A Case Report.治疗剂量下无慢性肾脏病个体发生的二甲双胍相关性乳酸酸中毒：一例报告

Cureus. 2023 Nov 12;15(11):e48683. doi: 10.7759/cureus.48683. eCollection 2023 Nov.

Pharmacokinetic relevance of glomerular hyperfiltration for drug dosing.肾小球高滤过对药物剂量的药代动力学相关性。

Clin Kidney J. 2023 Apr 10;16(10):1580-1586. doi: 10.1093/ckj/sfad079. eCollection 2023 Oct.

SGLT2i for evidence-based cardiorenal protection in diabetic and non-diabetic chronic kidney disease: a comprehensive review by EURECA-m and ERBP working groups of ERA.SGLT2抑制剂在糖尿病和非糖尿病慢性肾脏病中基于证据的心脏肾脏保护作用：欧洲肾脏协会（ERA）的EURECA-m和ERBP工作组的综合综述

Nephrol Dial Transplant. 2023 Oct 31;38(11):2444-2455. doi: 10.1093/ndt/gfad112.

Treating chronic kidney disease to reduce cardiovascular risk.治疗慢性肾脏病以降低心血管风险。

Eur Heart J Suppl. 2023 Apr 21;25(Suppl B):B50-B54. doi: 10.1093/eurheartjsupp/suad067. eCollection 2023 Apr.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验